Clinical efficacy of erlotinib, a salvage treatment for non-small cell lung cancer patients following gefitinib failure
Kyoung Min Cho, Bhumsuk Keam, Tae Min Kim, Se-Hoon Lee, Dong-Wan Kim, Dae Seog Heo
Korean J Intern Med. 2015;30(6):891-898.   Published online 2015 Oct 30     DOI: https://doi.org/10.3904/kjim.2015.30.6.891
Citations to this article as recorded by Crossref logo
Re-challenge of afatinib after 1st generation EGFR-TKI failure in patients with previously treated non-small cell lung cancer harboring EGFR mutation
Ou Yamaguchi, Kyoichi Kaira, Atsuto Mouri, Ayako Shiono, Kosuke Hashimoto, Yu Miura, Fuyumi Nishihara, Yoshitake Murayama, Kunihiko Kobayashi, Hiroshi Kagamu
Cancer Chemotherapy and Pharmacology.2019; 83(5): 817.     CrossRef
Gefitinib
Reactions Weekly.2016; 1629(1): 123.     CrossRef